Palisade Bio Inc (PALI)

May 06, 2026

Palisade Bio (PALI) price target decreased by 12.09% to 10.20 - MSN

May 06, 2026

May 05, 2026

Palisade Bio Data Supports Once-Daily Ulcerative Colitis Treatment Due to Sustained IC90 Coverage - geneonline.com

May 05, 2026

May 05, 2026

Palisade Bio presents pharmacokinetic data for ulcerative colitis drug By Investing.com - Investing.com South Africa

May 05, 2026

May 05, 2026

Palisade Bio presents pharmacokinetic data for ulcerative colitis drug - Investing.com

May 05, 2026

May 05, 2026

Palisade UC pill stayed above IC90 through the dosing interval - Stock Titan

May 05, 2026

May 05, 2026

Palisade Bio Reports Additional Phase 1a/b Data - GlobeNewswire

May 05, 2026

May 04, 2026

MSN Money - MSN

May 04, 2026

Apr 29, 2026

Major share increase and equity plan votes ahead for Palisade Bio (NASDAQ: PALI) - Stock Titan

Apr 29, 2026

Apr 28, 2026

Palisade Bio Participates in Virtual Investor "What This Means" Segment - 富途牛牛

Apr 28, 2026

Apr 27, 2026

Here's Why Palisade Bio (PALI) Could be Great Choice for a Bottom Fisher - MSN

Apr 27, 2026

Apr 25, 2026

PALI Should I Buy - Intellectia AI

Apr 25, 2026

Apr 22, 2026

PALI Palisade Bio posts narrower than expected Q4 2025 loss, shares gain more than four percent.Secondary Offering - Cổng thông tin điện tử tỉnh Lào Cai

Apr 22, 2026

Apr 21, 2026

Analysts Offer Predictions for Palisade Bio Q1 Earnings - MarketBeat

Apr 21, 2026

Apr 20, 2026

Brokers Issue Forecasts for Palisade Bio Q3 Earnings - MarketBeat

Apr 20, 2026

Apr 17, 2026

Palisade Bio (NASDAQ: PALI) asks shareholders to lift authorized shares to 450M - Stock Titan

Apr 17, 2026

Apr 17, 2026

Palisade Bio Develops Crohn’s Disease Treatment Following Positive Study - HarianBasis.co

Apr 17, 2026

Apr 17, 2026

Wolfe Highlights Differentiation Potential in Palisade Bio, Inc. (PALI) Clinical Profile - Insider Monkey

Apr 17, 2026

Apr 17, 2026

Palisade Bio to present ulcerative colitis data at DDW conference By Investing.com - Investing.com India

Apr 17, 2026

Apr 16, 2026

Palisade Bio to present ulcerative colitis data at DDW conference - Investing.com

Apr 16, 2026

Apr 16, 2026

Palisade Bio, Inc. Announces Poster Presentation at Digestive Disease Week® 2026 Featuring PALI-2108 Data on Ulcerative Colitis - Quiver Quantitative

Apr 16, 2026

Apr 16, 2026

Palisade Bio Announces Abstract Selected for Poster Presentation at Digestive Disease Week (DDW) 2026 - GlobeNewswire

Apr 16, 2026

Apr 16, 2026

5 Best Biotech Stocks Under $10 to Buy - Insider Monkey

Apr 16, 2026

Apr 13, 2026

Piper Sandler reiterates Overweight rating on Palisade Bio stock By Investing.com - Investing.com South Africa

Apr 13, 2026

Apr 13, 2026

Piper Sandler reiterates Overweight rating on Palisade Bio stock - Investing.com

Apr 13, 2026

Apr 11, 2026

Palisade Bio, Inc. (NASDAQ:PALI) Receives Consensus Recommendation of "Moderate Buy" from Analysts - MarketBeat

Apr 11, 2026

Apr 10, 2026

Should I invest in Palisade Bio Inc before earnings2026 Performance Recap & Expert Curated Trade Setup Alerts - baoquankhu1.vn

Apr 10, 2026

Apr 10, 2026

Wolfe Research Upgrades Palisade Bio (NASDAQ:PALI) to Strong-Buy - MarketBeat

Apr 10, 2026

Apr 09, 2026

Wolfe Research Begins Coverage on Palisade Bio (NASDAQ:PALI) - MarketBeat

Apr 09, 2026

Apr 08, 2026

Palisade Bio CEO, CMO to give virtual Needham presentation April 16 - Stock Titan

Apr 08, 2026

Apr 08, 2026

Palisade Bio to Present at the Needham & Co. 25th Annual Healthcare Conference - The Manila Times

Apr 08, 2026

Apr 08, 2026

Palisade Bio (PALI) reports positive phase 1b data for PALI-2108 in UC patients - MSN

Apr 08, 2026

Apr 08, 2026

Is Palisade Bio (PALI) Stock a future winner | Price at $1.94, Up 1.31%Trending Social Stocks - Cổng thông tin điện tử tỉnh Tây Ninh

Apr 08, 2026

Apr 07, 2026

Earnings Miss: Can Palisade Bio Inc expand its profit margins2026 Opening Moves & Weekly High Return Opportunities - baoquankhu1.vn

Apr 07, 2026

Apr 05, 2026

Analysts Conflicted on These Healthcare Names: Neumora Therapeutics, Inc. (NMRA), Palisade Bio (PALI) and AnaptysBio (ANAB) - The Globe and Mail

Apr 05, 2026

Apr 02, 2026

Palisade Bio partners with Iterative Health to advance PALI-2108 - TipRanks

Apr 02, 2026

Apr 02, 2026

Palisade Bio enters agreement with Iterative Health and completes $3 million stock sale - Investing.com Australia

Apr 02, 2026

Apr 02, 2026

Palisade Bio raises $3.0M from Iterative Health affiliate to support PALI-2108 Phase 2 enrollment - TradingView

Apr 02, 2026